All of them aim to stimulate an immune response against the spike protein. This protein is found ... chemical company on phase I/II trials to test the feasibility of delivering their vaccine ...

Their new tool, AF2Complex, used deep learning to predict which antibodies could bind to COVID-19's infamous spike protein ..